Rebate Intelligence & Assurance

Manufacturer follow-up, from invoice to reconciliation.

Manufacturers view invoices, report payments, and resolve disputes in a structured portal instead of an email thread. It is a supporting experience within IXB Rebate & Contract Financial Integrity — portal activity stays connected to the rebate lifecycle your team reconciles.

Managed follow-up

IXB keeps manufacturer follow-up moving.

Invoice delivery and tracking

IXB tracks whether invoices have been sent, viewed, acknowledged, disputed, or left idle.

Follow-up on open items

When manufacturer action is pending, IXB follows up on unacknowledged invoices, missing payment reports, aging disputes, and reconciliation exceptions.

Escalation and closeout

Aging items are surfaced, documented, and moved through a structured workflow until they are resolved, paid, reconciled, or closed.

Portal workflows

One place for manufacturers to respond and customers to track status.

For manufacturers

View invoices

See issued invoices with line-item detail and the contract terms behind each calculation.

Report payments

Submit payment details directly against the invoice they pay.

Manage disputes

Open, document, and resolve disputed line items in a structured workflow.

For customers

Track invoice status

See what is outstanding, paid, partially paid, disputed, or awaiting action.

Monitor disputes

Review dispute activity tied to specific invoice lines instead of disconnected inbox threads.

Reconcile payments

Match reported payments back to the invoices, claims, and expected rebate amounts that generated them.

Representative portal view

An invoice with the full dispute history attached.

A representative invoice detail view as a manufacturer would see it. Line items, dispute notes, payment activity, and supporting documentation stay attached to the invoice instead of living in a parallel email chain.

manufacturer.ixb.com
Mfr-C · AR Team
Invoices › 2026 · Q3 › INV-2026-0418

Invoice INV-2026-0418

Acme PCN · Master 2026 · Q3 2026 · Issued Oct 5, 2026
DISPUTE OPEN · 7d
Invoiced$27,640.00
Under dispute$2,840.00
Approved to pay$24,800.00
DueNov 4, 2026
Line items 3 of 12 shown
NDCDrugTierClaimsRebateStatus
00378-1234Atorvastatin 20mgTier 11,284$12,840.00Accepted
00378-5678Esomeprazole 40mgTier 2 · MS421$8,210.00Dispute open
00378-9012Metformin XR 750mgTier 12,140$4,002.00Accepted
Dispute thread · 00378-5678 3 messages · Plan: Acme PCN
Mfr-C · AR TeamOct 12, 2026 · 10:24

Market-share tier appears applied at 8.4% but our calculation shows 7.2% for this period. Requesting review against the Q3 contract amendment effective Aug 1.

Q3-MS-calculation.xlsx
Acme PCN · Rebate OpsOct 14, 2026 · 14:08

Reviewing against contract amendment v3.1. Initial check shows tier was calculated against the prior period; recalculation in progress. Will respond by Oct 17.

Representative view. Numbers and names shown are illustrative.

Access is scoped to the manufacturer.A manufacturer sees only the invoices, lines, and dispute history that belong to them. Other manufacturers’ contract terms and plan-side economics are not exposed through the portal.
Get in touch

Let's talk about manufacturer follow-up.

Tell us how much of your reconciliation still happens over email.